- The FDA approved a coronavirus trial of a drug that’s used to treat erectile dysfunction, among other things.
- The drug showed promise in treating ARDS, a common COVID-19 complication for severe cases that require ventilation therapy.
- If the trial is successful, the drug could be used to treat up to 100,000 critical cases.
- Visit BGR’s homepage for more stories.
One of the problems with highly contagious new viruses like the SARS-CoV-2 that causes COVID-19 is that there’s no line of treatment when the outbreak starts. Doctors in China and other countries have tried all sorts of therapies to mitigate the effects of the novel coronavirus on the body. They’ve been using existing drugs that have been approved for other ailments, to treat symptoms, speed up recovery times, and attempt to save critical patients. That’s because it takes time to develop a drug that can deal with the new virus, just as it takes time to come up with a vaccine that could immunize the general population.
All sorts of substances have been tried to mitigate infections and kill the virus, including antiviral therapies for HIV, anti-malarial drugs, and medicine that treats heart disease, to name just a few. The latest addition to the list is a drug called Aviptadil (VIP) that’s used to treat erectile dysfunction, among other things.
Today’s Top Deals
- Today’s top deals: Massive Anker sale, $25 Fire TV Stick 4K, $14 headphones, $5 Alexa smart plugs, $20 home cam, more
- Today’s best deals: $9 wireless charger, Fire TV Stick deals, UV phone sanitizers, $20 home camera, Fitbit sale, more
- These $42 earbuds sound better than AirPods and have twice the battery life
Trending Right Now:
- AI tool finds 3 coronavirus signs that often lead to a severe case
- Coronavirus update: Here’s an estimate of when the worst will hit your state
- AT&T adds another freebie to help customers stay connected during the coronavirus crisis
An erectile dysfunction drug might improve critical coronavirus cases originally appeared on BGR.com on Wed, 1 Apr 2020 at 07:31:54 EDT. Please see our terms for use of feeds.
Read more here:: Boy Genius Report